A case of relapsing aseptic meningitis under excellent tumor response to pembrolizumab in microsatellite instability-high recurrent endometrial cancer
Authors:
Open Access
- 23 October 2021
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 38, 100885
Abstract
No abstract availableKeywords
Funding Information
- Jikei University School of Medicine
This publication has 7 references indexed in Scilit:
- Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patientsEuropean Journal of Cancer, 2019
- Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint InhibitorsClinical Pharmacokinetics, 2019
- Landscape of Microsatellite Instability Across 39 Cancer TypesJCO Precision Oncology, 2017
- Neurological adverse events associated with immune checkpoint inhibitors: Review of the literatureEuropean Journal of Cancer, 2017
- Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literatureAnnals of Oncology, 2016
- Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup studyGynecologic Oncology, 2013
- Use of Glucocorticoids and Risk of Venous ThromboembolismJAMA Internal Medicine, 2013